Send us Feedback

Tekmira Pharmaceuticals (TKM)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter 2012 Results
Globe Newswire  May 9  Comment 
VANCOUVER, British Columbia, May 9, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on
Tekmira Conference Call and Webcast Advisory: Corporate Update and 2011 Audited Results
Globe Newswire  Mar 22  Comment 
VANCOUVER, British Columbia, March 22, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on
Tekmira Files Motion to Dismiss in Patent Infringement Suit
Globe Newswire  Mar 6  Comment 
VANCOUVER, British Columbia, March 6, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, disclosed that it has responded to the patent infringement
Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation
Globe Newswire  Feb 9  Comment 
VANCOUVER, B.C., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that the United States Patent & Trademark Office (USPTO) has
Tekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia
Benzinga  Jan 10  Comment 
Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR) disclosed today that the Supreme Court of British Columbia granted Tekmira's application for an injunction that orders confidential documents and materials be returned to Tekmira and prohibits the...
Tekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial
Globe Newswire  Nov 28  Comment 
VANCOUVER, British Columbia, Nov. 28, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that its Investigational New Drug (IND)
Tekmira Pharmaceuticals (TKMR) Files Notice of Civil Claim in Supreme Court of British Columbia Against Individuals from AlCana Technologies
StreetInsider.com  Nov 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Tekmira+Pharmaceuticals+%28TKMR%29+Files+Notice+of+Civil+Claim+in+Supreme+Court+of+British+Columbia+Against+Individuals+from+AlCana+Technologies/6954802.html for the full story.
Tekmira Pharmaceuticals (TKMR) Acquires Worldwide Exclusive License to Novel RNAi Platform
StreetInsider.com  Aug 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Tekmira+Pharmaceuticals+%28TKMR%29+Acquires+Worldwide+Exclusive+License+to+Novel+RNAi+Platform/6742480.html for the full story.
Tekmira Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update
Globe Newswire  Aug 4  Comment 
VANCOUVER, British Columbia, Aug. 4, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity
Globe Newswire  Jun 6  Comment 
VANCOUVER, B.C., June 6, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today provided comments on recently presented data from a Phase I human




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Tekmira_Pharmaceuticals_(TKM)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki